Spotlight: Nov 1, 2026 Engineers have developed a nanoscale particle for delivering personalized cancer vaccines. The particle could be adapted to carry many different antigens, to potentially prevent or treat individual patients’ tumors. Nov 1, 2026 Full story Share: Twitter Facebook Credit: Jose-Luis Olivares, MIT
